Quick Takeaways: Why It Matters? PetVivo’s new study shows that a single intra-articular Spryng injection with OsteoCushion technology can improve pain and function in dogs with stifle osteoarthritis and suspected cranial cruciate disease. While the authors call for larger studies with obj...
Featured Article Cover Story Regulatory Updates Research Updates Product Launch Retail expansion Dechra Opens Global Headquarters in Boston Corporate update Dechra has opened its new global headquarters in Boston, strengthening its innovation footprint while supporting community programs t...
Quick Takeaways: Why It Matters? The Texas A&M study positions Pictor’s PictVet assay as a highly accurate, non‑invasive tool for monitoring Mycoplasma bovis–associated immune responses in beef cattle, supporting broader use of targeted proteomics in her...
Featured Article Cover Story Research Updates Regulatory Approval Product Launches Elanco Launches $25 Million Venture Fund Innovation platform Elanco Animal Health plans to launch Elanco Ventures, a $25 million corporate venture platform to back early-stage animal health innovation. Key h...
Quick Takeaways: Why It Matters? AKC Canine Health Foundation is elevating canine geroscience from scattered projects to a focused Aging program, anchored by new global guidelines that standardize how vets diagnose and monitor Canine Cognitive Dysfunction Sy...
Quick Takeaways: Why It Matters? The strong equine proof‑of‑concept data, clean safety profile, and upcoming human knee OA feasibility study collectively de‑risk Hydrocelin’s translational path, increasing its attractiveness as a first‑in‑class, potentially disease‑mo...
Quick Takeaways: Why It Matters? BE-101’s move into pivotal field safety testing brings the poultry sector closer to a commercially viable, non-antibiotic solution for necrotic enteritis, addressing a major economic and welfare burden while aligning with global pressure to...
Quick Takeaways: Why It Matters? Data for LPT‑CBD strengthens the scientific case for long‑acting, injectable CBD as a legitimate chronic pain option, not just a wellness supplement, which can increase veterinarian openness to cannabinoid-based therapies. The sustaine...
Quick Takeaways: Why It Matters? The collaboration validates structural surfaceomics as a serious next-gen discovery tool in animal health, not just a niche academic technology. If it yields novel, conformation-specific targets, it could pave ...
20. ImmuCell Revenue: $17.47M Founded Year: 1987 Market Cap: Total Employees: ~100 Headquarters: Portland, United States Stock Exchange: NASDAQ 19. Hester Biosciences Revenue: $33.24M Founded Year: 1987 Market Cap: Total Employees: ~600 Headquarters: Gujrat, India Stock Exchange: NSE 18. V...
